Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Cost of Goods Sold

Rigel Pharmaceuticals Cost of Goods Sold Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Rigel Pharmaceuticals Cost of Goods Sold for the quarter ending June 06, 2020 was $14m a -1.93% decrease of 0m year over year
  • Rigel Pharmaceuticals Cost of Goods Sold for the last 12 months ending June 06, 2020 was $60m a 11.12% increase of 7m year over year
  • Rigel Pharmaceuticals Annual Cost of Goods Sold for 2019 was $54m a 12.27% increase of 7m from 2018
  • Rigel Pharmaceuticals Annual Cost of Goods Sold for 2018 was $47m a 1.95% increase of 1m from 2017
  • Rigel Pharmaceuticals Annual Cost of Goods Sold for 2017 was $46m a -37.12% decrease of -17m from 2016
Other Income Statement Metrics:
  • Rigel Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $3m a 1,013.58% increase of 27m year over year
  • Rigel Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $3m a 855.42% increase of 28m year over year
  • Rigel Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $5m a 26.33% increase of 1m year over year
View Chart On Koyfin

Quarterly RIGL Cost of Goods Sold Data

06/2020$14m
03/2020$16m
12/2019$14m
09/2019$15m
06/2019$14m
03/2019$11m
12/2018$14m
09/2018$11m
06/2018$11m
03/2018$11m

Annual RIGL Cost of Goods Sold Data

2019$54m
2018$47m
2017$46m
2016$63m
2015$63m
2014$68m
2013$75m
2012$79m
2011$69m
2010$48m